Company type | Public |
---|---|
Nasdaq: CYCC | |
Industry | Biotechnology |
Founded | 1997 |
Founder | David P. Lane, PhD |
Headquarters | Berkeley Heights, New Jersey, U.S. |
Key people | Spiro Rombotis (CEO) Paul McBarron (EVP, finance & COO) Mark Kirschbaum, MD (CMO) |
Products | Fadraciclib (formerly CYC065), CYC140 |
US$ 19.1 million (2021) | |
Number of employees | 17 (2022) |
Website | cyclacel |
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD.